Clinical trial for Long Covid
Official title Periodic Fasting for Treatment of Long Covid in Adults: a Pilot Study
ClinicalTrials.gov ID: NCT06522750
What this study is testing
- What it's testing
- The study wants to see if a 7‑day fast is doable and how it might change symptoms, blood markers, and mood over 4 weeks.
- Who it's for
- Adults who still have long COVID symptoms after their initial infection.
- What's involved
- Participants will fast for 7 days under medical supervision, then have blood and stool tests and fill out questionnaires on a smartphone app.
- Time commitment
- The study lasts 4 weeks, with visits for fasting, blood draws, stool collection, and app questionnaires.
- Time commitment: about 4 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 64
You may be able to join if
- Age 18-64
- Diagnosis Long Covid Syndrome (post-acute COVID-19 symptoms persisting ≥12 weeks)
- Normal body Mass Index (18.5 to 25 kg/m2)
- Marginal Iron status ( PF\< 25 ng/ml)
- Able to communicate in and comprehend English and/or German and/or French language
You likely can't join if
- Current underweight condition (body mass index less than 18.5 kg/m2) or weight loss exceeding 3 kg within the last month or 5 kg within the last...
- Existing / current eating disorder within the past five years (e.g., anorexia, bulimia).
- Psychiatric condition that limits understanding of the examination protocol (unable to consent)
- Severe internal disease (e.g. kidney deficiency with creatinine \> 2mg/dl), chronic inflammatory illness other than LCS
- Participation in another intervention study.
- Existing vegan diet or fasting during the last six months
See the full eligibility criteria
- Age 18-64
- Diagnosis Long Covid Syndrome (post-acute COVID-19 symptoms persisting ≥12 weeks)
- Normal body Mass Index (18.5 to 25 kg/m2)
- Marginal Iron status ( PF\< 25 ng/ml)
- Able to communicate in and comprehend English and/or German and/or French language
- Present written / signed declaration of consent
- Ability to understand the patient information and willingness to sign the consent form
- Consent to specimen collection and specimen use
- Current underweight condition (body mass index less than 18.5 kg/m2) or weight loss exceeding 3 kg within the last month or 5 kg within the last three months.
- Existing / current eating disorder within the past five years (e.g., anorexia, bulimia).
- Psychiatric condition that limits understanding of the examination protocol (unable to consent)
- Severe internal disease (e.g. kidney deficiency with creatinine \> 2mg/dl), chronic inflammatory illness other than LCS
- Participation in another intervention study.
- Existing vegan diet or fasting during the last six months
- Pregnancy or breastfeeding status.
- Presence or suspicion of pre-existing ME/CFS or early autonomous dysfunction
- Diagnosis of chronic inflammatory bowel diseases, celiac disease or colorectal cancer according to the guidelines of the German Society of Gastroenterology
- Use of anti-psychotic drugs
- Antibiotic use during the previous 12 months
- Start of novel drug therapy
- Contraindication for additional blood draws (e.g. hemoglobin \<10)
The study team makes the final eligibility decision.
Where it is enrolling
- Ettelbruck, Luxembourg
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Ettelbruck, Luxembourg. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.